PonsusPharma
STOCKHOLM, Ponsus Pharma has appointed Mats Silvander, Ph.D. as the new Research & Development Manager. His main area of focus will be to further develop the patented Proderm Technology® pharmaceutical product lines. Until recently Silvander was Vice President of Product Development of Quinnova Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of prescription drug products based on innovative topical drug delivery platforms. He has a strong record of bringing to market products of large customer value.
“I am glad to be part of the Ponsus team. The prospects for the advanced topical products such as the Proderm line are truly great. We will continue to meet our customers’ needs of modern topical products based on high quality innovations,”
Also, Dan Johansson, M.Sc. was named Sales and Marketing Manager. His most recent position was Global Product Specialist for Dako A/S managing their portfolio of concentrated antibodies.
“I see a great potential in the Proderm Technology. It is very rewarding to develop high quality products for our customers. I see that there is a need for pharmaceutical products that the customers actually use instead of just putting it in storage, and which increases consumer compliance”, says Johansson.
“Ponsus Pharma has been working along with Quinnova Pharmaceuticals, Inc. to successfully launch prescription pharmaceutical products based on Proderm Technology, in the U.S. and now we are looking for the ideal partner for a European collaboration. The addition of Mats and Dan to the Ponsus Pharma team will allow us to move forward towards our goal of EU market acceptance for Proderm Technology” stated Lars Blak, CEO of Ponsus Pharma.
Photo:
http://www.prlog.org/
